Current Medicinal Chemistry
Title:Editorial: Bioactive Fungal Metabolites
Volume: 25 Issue: 2
Author(s): Antonio Evidente and Robert Kiss
Affiliation:
Export Options
About this article
Cite this article as:
Evidente Antonio and Kiss Robert , Editorial: Bioactive Fungal Metabolites, Current Medicinal Chemistry 2018; 25 (2) . https://dx.doi.org/10.2174/092986732502180122153435
DOI https://dx.doi.org/10.2174/092986732502180122153435 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
51
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functions of Antimicrobial Peptides in Vertebrates
Current Protein & Peptide Science Rock1 & 2 Perform Overlapping and Unique Roles in Angiogenesis and Angiosarcoma Tumor Progression
Current Molecular Medicine Anti-cancer Peptides from Ras-P21 and P53 Proteins
Current Pharmaceutical Design 99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents
Anti-Cancer Agents in Medicinal Chemistry Prognostic and Predictive Molecular Markers in Cutaneous Malignant Melanoma: The First Step Toward Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-EGFR and Anti-VEGF Molecules
Current Drug Metabolism Prothymosin Alpha: An Alarmin and More...
Current Medicinal Chemistry Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches
Current Cancer Drug Targets Phosphonomethoxyalkyl Analogs of Nucleotides
Current Pharmaceutical Design Smart Stimuli Sensitive Nanogels in Cancer Drug Delivery and Imaging: A Review
Current Pharmaceutical Design Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design RAGE and RAGE Ligands in Cancer
Current Molecular Medicine Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Qigefang Inhibits Migration, Invasion, and Metastasis of ESCC by Inhibiting Gas6/Axl Signaling Pathway
Recent Patents on Anti-Cancer Drug Discovery Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia
Current Pharmaceutical Design Specificity of Binding in Protein Kinases
Current Enzyme Inhibition Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Current Genomics Role of Fc Receptors as a Therapeutic Target
Inflammation & Allergy - Drug Targets (Discontinued) Pixuvri<sup>®</sup> (Pixantrone Dimaleate, BBR 2778): From Lab to Market
Current Organic Chemistry Targeted Therapies in Hepatocellular Carcinoma
Current Medicinal Chemistry